{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:10:44Z","timestamp":1778911844945,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Farma S.p.A.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>There is limited evidence on the scope and overall benefit of patient-centred drug development decisions. The present study assessed patients\u2019 preferences for the characteristics of an ideal migraine treatment through a discrete choice experiment in order to inform decision-making and drug development processes. We investigated the preferences according to five treatment attributes identified from a systematic literature review and two focus group elicitations. The heterogeneity of preferences was also investigated. Overall, the respondents considered the presence of adverse events, duration of treatment effect, reduction of symptom intensity, speed of effect and cost born by the patient as the most relevant treatment features. As expected, the patients preferred treatments with lower levels of adverse events and costs and treatments with greater speed, duration of treatment effect and effectiveness in reducing symptom intensity. There was significant preference heterogeneity only for the presence of adverse events. Compared to men, women had significantly higher preferences for quicker treatment effect and limited adverse events and reported higher preferences for costly treatments. The results of our survey help address research and development strategies in the pharmaceutical industry and public policy regarding treatments that are clinically effective and responsive to the needs expressed by patients.<\/jats:p>","DOI":"10.3390\/ijerph18094916","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:06:01Z","timestamp":1620212761000},"page":"4916","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigating Patients\u2019 Preferences to Inform Drug Development Decisions: Novel Insights from a Discrete Choice Experiment in Migraine"],"prefix":"10.3390","volume":"18","author":[{"given":"Aleksandra","family":"Torbica","sequence":"first","affiliation":[{"name":"CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy"},{"name":"Department of Social and Political Sciences, Bocconi University, 20136 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-0591","authenticated-orcid":false,"given":"Carla","family":"Rognoni","sequence":"additional","affiliation":[{"name":"CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[{"name":"CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy"},{"name":"Department of Social and Political Sciences, Bocconi University, 20136 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jval.2016.04.009","article-title":"Increasing Patient Involvement in Drug Development","volume":"19","author":"Lowe","year":"2016","journal-title":"Value Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/2168479015579521","article-title":"Establishing Return-on-Investment Expectations for Patient-Centric Initiatives","volume":"49","author":"Getz","year":"2015","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Steiner, T.J., Stovner, L.J., Katsarava, Z., Lainez, J.M., Lampl, C., Lant\u00e9ri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., and Barr\u00e9, J. (2014). The Impact of Headache in Europe: Principal Results of the Eurolight Project. J. Headache Pain, 15.","DOI":"10.1186\/1129-2377-15-31"},{"key":"ref_4","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016). Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 310 Diseases and Injuries, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1545\u20131602."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","article-title":"Cost-of-Illness Analysis. What Room in Health Economics?","volume":"77","author":"Tarricone","year":"2006","journal-title":"Health Policy"},{"key":"ref_6","unstructured":"(2021). Emicrania: Impatto Sociale ed Economico in Italia [Migraine: Social and Economic Impact in Italy], Springer Healthcare."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.33393\/abtpn.2020.2189","article-title":"Socioeconomic Impact of Migraine in Italy: Results of a National Survey","volume":"7","author":"Nica","year":"2020","journal-title":"AboutOpen"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10194-005-0164-3","article-title":"Patients\u2019 Preference for Triptans and Other Medications as a Tool for Assessing the Efficacy of Acute Treatments for Migraine","volume":"6","author":"Dowson","year":"2005","journal-title":"J. Headache Pain"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gonzalez, J.M., Hauber, A.B., Levitan, B., and Coplan, P. (2012). PND36 Structured Benefit-Risk Assessment of Triptan Treatments Using Patient-Preference Data. Value Health, 15.","DOI":"10.1016\/j.jval.2012.03.795"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mitsikostas, D.D., Belesioti, I., Arvaniti, C., Mitropoulou, E., Deligianni, C., Kasioti, E., Constantinidis, T., Dermitzakis, M., and Vikelis, M. (2017). Patients\u2019 Preferences for Headache Acute and Preventive Treatment. J. Headache Pain, 18.","DOI":"10.1186\/s10194-017-0813-3"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1526-4610.2007.00757.x","article-title":"Patients\u2019 Preference for Migraine Preventive Therapy","volume":"47","author":"Peres","year":"2007","journal-title":"Headache"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/head.12142","article-title":"Evaluating Migraineurs\u2019 Preferences for Migraine Treatment Outcomes Using a Choice Experiment","volume":"53","author":"Gonzalez","year":"2013","journal-title":"Headache"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/jwh.2018.7274","article-title":"Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps","volume":"27","author":"Schroeder","year":"2018","journal-title":"J. Women\u2019s Health"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cook, N.S., Cave, J., and Holtorf, A.-P. (2019). Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00082"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force","volume":"16","author":"Lancsar","year":"2013","journal-title":"Value Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1755-5345(13)70016-2","article-title":"Design of Discrete Choice Experiments: A Discussion of Issues That Matter in Future Applied Research","volume":"4","author":"Louviere","year":"2011","journal-title":"J. Choice Model."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","article-title":"Discrete Choice Experiments in Health Economics: A Review of the Literature","volume":"21","author":"Ryan","year":"2012","journal-title":"Health Econ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","article-title":"Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User\u2019s Guide","volume":"26","author":"Lancsar","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1468-2982.2001.218256.x","article-title":"Assessing Patient Preference in Migraine Treatment","volume":"21","year":"2001","journal-title":"Cephalalgia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1468-2982.2005.00797.x","article-title":"An Assessment of the Burden of Migraine Using the Willingness to Pay Model","volume":"25","author":"Hamelsky","year":"2005","journal-title":"Cephalalgia"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2011). 15th Congress of the International Headache Society 23-26 June 2011, Berlin, Germany. Cephalalgia, 31, 1\u2013216.","DOI":"10.1177\/0021955X11414520"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1468-2982.2004.00677.x","article-title":"Patient Preference in Clinical Trials for Headache Medication: The Patient\u2019s View","volume":"24","author":"Bertheau","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.MLR.0000044909.63278.0D","article-title":"Use of Willingness to Pay to Study Values for Pharmacotherapies for Migraine Headache","volume":"41","author":"Lenert","year":"2003","journal-title":"Med. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","article-title":"What Do Patients with Migraine Want from Acute Migraine Treatment?","volume":"42","author":"Lipton","year":"2002","journal-title":"Headache"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Manandhar, K., Risal, A., Linde, M., and Steiner, T.J. (2016). The Burden of Headache Disorders in Nepal: Estimates from a Population-Based Survey. J. Headache Pain, 17.","DOI":"10.1186\/s10194-016-0594-0"},{"key":"ref_26","first-page":"147","article-title":"Comparison of Expected Outcomes between Patients and Neurologists Using Kano\u2019s Methodology in Symptomatic Migraine Treatment","volume":"5","author":"Caloto","year":"2012","journal-title":"Patient"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Smelt, A.F.H., Louter, M.A., Kies, D.A., Blom, J.W., Terwindt, G.M., van der Heijden, G.J.M.G., Gucht, V.D., Ferrari, M.D., and Assendelft, W.J.J. (2014). What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098933"},{"key":"ref_28","unstructured":"(2021, April 02). Focus Groups: A Practical Guide for Applied Research\/Richard A. Krueger & Mary Anne Casey\u2014Trove, Available online: https:\/\/trove.nla.gov.au\/work\/11230018."},{"key":"ref_29","unstructured":"Center for Drug Evaluation and Research (2019). FDA Adverse Event Reporting System (FAERS) Public Dashboard."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-018-0324-6","article-title":"Including Opt-Out Options in Discrete Choice Experiments: Issues to Consider","volume":"12","author":"Campbell","year":"2019","journal-title":"Patient"},{"key":"ref_31","unstructured":"(2021, April 02). ChoiceMetrics. Available online: http:\/\/www.choice-metrics.com\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/bdm.622","article-title":"The Construction of Optimal Stated Choice Experiments, Theory and Methods, (1st Ed., 312 Pp. Hardback). By D. J. Street, & L. Burgess Hoboken: Wiley (2007). ISBN: 978-0-470-05332-4","volume":"22","author":"Ishizaka","year":"2009","journal-title":"J. Behav. Decis. Mak."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample Size Requirements for Discrete-Choice Experiments in Healthcare: A Practical Guide","volume":"8","author":"Donkers","year":"2015","journal-title":"Patient"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/259131","article-title":"A New Approach to Consumer Theory","volume":"74","author":"Lancaster","year":"1966","journal-title":"J. Political Econ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0148-2963(02)00352-1","article-title":"Using Stated Preference Discrete Choice Modeling to Evaluate Health Care Programs","volume":"57","author":"Hall","year":"2004","journal-title":"J. Bus. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhealeco.2007.11.006","article-title":"Modelling Heterogeneity in Patients\u2019 Preferences for the Attributes of a General Practitioner Appointment","volume":"27","author":"Hole","year":"2008","journal-title":"J. Health Econ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2307\/1240800","article-title":"Welfare Evaluations in Contingent Valuation Experiments with Discrete Responses","volume":"66","author":"Hanemann","year":"1984","journal-title":"Am. J. Agric. Econ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40273-017-0506-4","article-title":"Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software","volume":"35","author":"Lancsar","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"ref_39","unstructured":"Center for Drug Evaluation and Research (2020). CDER Patient-Focused Drug Development."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cpt.332","article-title":"Incorporating Patient Preferences into Drug Development and Regulatory Decision Making: Results from a Quantitative Pilot Study with Cancer Patients, Carers, and Regulators","volume":"99","author":"Postmus","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_41","unstructured":"(2021, April 02). What Is EUPATI?. Available online: https:\/\/www.eupati.eu."},{"key":"ref_42","unstructured":"Holm, A. (2021, April 02). About PREFER\u2014PREFER. Available online: https:\/\/www.imi-prefer.eu\/about\/."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1751-5823.2010.00112.x","article-title":"Selection Bias in Web Surveys","volume":"78","author":"Bethlehem","year":"2010","journal-title":"Int. Stat. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Louviere, J.J., Hensher, D.A., Swait, J.D., and Adamowicz, W. (2000). Stated Choice Methods: Analysis and Applications, Cambridge University Press. [1st ed.].","DOI":"10.1017\/CBO9780511753831"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4916\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:57:17Z","timestamp":1760162237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijerph18094916"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18094916","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-50243\/v1","asserted-by":"object"}]},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]}}}